Patient Selection, Outcome and Clinical Efficacy of TIPS: A Single Center Experience and Review of the Literature
Abstract
Background/Aim: Transjugular intrahepatic portosystemic shunt (TIPS) is known to be an efficient procedure for decompression of portal hypertension and control of consecutive complications. We analyzed our experience with the efficacy and complications of the procedure in a variety common and uncommon indications. Methods: In this single center retrospective analysis, 38 patients with different symptoms complicating portal hypertension, including portal vein thrombosis and non-variceal GI-bleeding, were treated by TIPS. Treatment was performed in conscious sedation and guided by ultrasonography and fluoroscopy, using polytetrafluorethylene-covered stents. Results: The rate of technically successful interventions was 98%. All shunts were patent during the follow up period of 36 months. The clinical disorders leading to TIPS implantation, such as ascites and variceal bleeding were successfully treated in all cases. The most frequent complication was transient encephalopathy (40%). TIPS dysfunction with reoccurrence of initial symptoms was noted in 39%, and treated successfully in all cases. 8/38 patients died during the follow up period, mostly due to progressive deterioration of liver function or to non-hepatic reasons. Conclusion: In conclusion, this study confirms TIPS to be a safe and effective procedure for treatment of different complications associated to portal hypertension. Our results as well as a review of the current literature suggest TIPS to be the standard treatment in patients with refractory ascites and Budd-Chiari syndrome, and to be of emerging significance in the management of portal thrombosis. In addition, TIPS maybe of value in new indications, such as obscure non-variceal bleeding associated with portal hypertension.
Keywords
References
Punamiya SJ, Amarapurkar DN. Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease. Int J Hepatol 2011; 2011: 398291
Rossle M, Siegerstetter V, Huber M, Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998; 18(2): 73-89
Riggio O, Ridola L, Lucidi C, Angeloni S. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines? Dig Liver Dis 2010; 42(7): 462-467
Palikhe M, Xue H, Jha RK, Li YC, Yuan J, Wang J, Zhang M. Changes in portal hemodynamics after TIPS in liver cirrhosis and portal hypertension. Scand J Gastroenterol 2013; 48(5): 570-576
Hausegger KA, Karnel F, Georgieva B, Tauss J, Portugaller H, Deutschmann H, Berghold A. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. Journal of vascular and interventional radiology : JVIR 2004; 15(3): 239-248
Busk TM, Bendtsen F, Moller S. Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis. Eur J Gastroenterol Hepatol 2013; 25(5): 523-530
Goykhman Y, Ben-Haim M, Rosen G, Carmiel-Haggai M, Oren R, Nakache R, Szold O, Klausner J, Kori I. Transjugular intrahepatic portosystemic shunt: current indications, patient selection and results. Isr Med Assoc J 2010; 12(11): 687-691
Rossle M. TIPS: 25 years later. Journal of hepatology 2013; 59(5): 1081-1093
Peter P, Andrej Z, Katarina SP, Manca G, Pavel S. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with recurrent variceal hemorrhage. Gastroenterology research and practice 2013; 2013: 398172
Yang Z, Han G, Wu Q, Ye X, Jin Z, Yin Z, Qi X, Bai M, Wu K, Fan D. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. Journal of gastroenterology and hepatology 2010; 25(11): 1718-1725
Rossle M, Siegerstetter V, Euringer W, Olschewski M, Kromeier J, Kurz K, Langer M. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients. Acta radiologica (Stockholm, Sweden : 1987) 2006; 47(7): 660-666
Riggio O, Angeloni S, Ridola L, Rossi P. Can an incomplete stent expansion modulate the effects of TIPS? J Gastroenterol 2010; 45(3): 346-347; author reply 348
Saad WE, Darwish WM, Davies MG, Kumer S, Anderson C, Waldman DL, Schmitt T, Matsumoto AH, Angle JF. Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome. AJR American journal of roentgenology 2013; 200(1): 210-218
Perarnau JM, Baju A, D'Alteroche L, Viguier J, Ayoub J. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol 2010; 22(9): 1093-1098
Anderson CL, Saad WE, Kalagher SD, Caldwell S, Sabri S, Turba UC, Matsumoto AH, Angle JF. Effect of transjugular intrahepatic portosystemic shunt placement on renal function: a 7-year, single-center experience. Journal of vascular and interventional radiology : JVIR 2010; 21(9): 1370-1376
Siramolpiwat S. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications. World journal of gastroenterology : WJG 2014; 20(45): 16996-17010
Rossle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 2010; 59(7): 988-1000
Garcia-Pagan JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG, Nevens F, Vinel JP, Mossner J, Bosch J. Early use of TIPS in patients with cirrhosis and variceal bleeding. The New England journal of medicine 2010; 362(25): 2370-2379
Garcia-Pagan JC, Di Pascoli M, Caca K, Laleman W, Bureau C, Appenrodt B, Luca A, Zipprich A, Abraldes JG, Nevens F, Vinel JP, Sauerbruch T, Bosch J. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. Journal of hepatology 2013; 58(1): 45-50
Shi KQ, Liu WY, Pan ZZ, Lin XF, Chen SL, Chen YP, Fan YC, Zheng MH. Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysis. Eur J Clin Invest 2013
Seijo S, Plessier A, Hoekstra J, Dell'era A, Mandair D, Rifai K, Trebicka J, Morard I, Lasser L, Abraldes JG, Darwish Murad S, Heller J, Hadengue A, Primignani M, Elias E, Janssen HL, Valla DC, Garcia-Pagan JC. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology (Baltimore, Md) 2013; 57(5): 1962-1968
Joshi D, Saha S, Bernal W, Heaton N, Wendon J, Auzinger G. Haemodynamic response to abdominal decompression in acute Budd-Chiari syndrome. Liver international : official journal of the International Association for the Study of the Liver 2011; 31(8): 1171-1178
Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nature reviews Gastroenterology & hepatology 2014; 11(7): 435-446
Liu L, Zhao Y, Qi X, Cai G, He C, Guo W, Yin Z, Chen H, Chen X, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res 2013
Rossi C, Zambruni A, Ansaloni F, Casadei A, Morelli C, Bernardi M, Trevisani F. Combined mechanical and pharmacologic thrombolysis for portal vein thrombosis in liver-graft recipients and in candidates for liver transplantation. Transplantation 2004; 78(6): 938-940
Senzolo M, T MS, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P, Tsochatzis E, K AB. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver international : official journal of the International Association for the Study of the Liver 2012; 32(6): 919-927
Hall TC, Garcea G, Metcalfe M, Bilku D, Dennison AR. Management of acute non-cirrhotic and non-malignant portal vein thrombosis: a systematic review. World journal of surgery 2011; 35(11): 2510-2520
Spaander VM, van Buuren HR, Janssen HL. Review article: The management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adults. Alimentary pharmacology & therapeutics 2007; 26 Suppl 2: 203-209
Luo X, Nie L, Zhou B, Yao D, Ma H, Jiang M, Zhang H, Li X. Transjugular intrahepatic portosystemic shunt for the treatment of portal hypertension in noncirrhotic patients with portal cavernoma. Gastroenterology research and practice 2014; 2014: 659726
De Palma GD, Rega M, Masone S, Persico F, Siciliano S, Patrone F, Matantuono L, Persico G. Mucosal abnormalities of the small bowel in patients with cirrhosis and portal hypertension: a capsule endoscopy study. Gastrointestinal endoscopy 2005; 62(4): 529-534
Abdelaal UM, Morita E, Nouda S, Kuramoto T, Miyaji K, Fukui H, Tsuda Y, Fukuda A, Murano M, Tokioka S, Arafa UA, Kassem AM, Umegaki E, Higuchi K. Evaluation of portal hypertensive enteropathy by scoring with capsule endoscopy: is transient elastography of clinical impact? Journal of clinical biochemistry and nutrition 2010; 47(1): 37-44
Pezzoli A, Fusetti N, Simone L, Zelante A, Cifala V, Carella A, Gullini S. Portal hypertensive enteropathy diagnosed by capsule endoscopy and demonstration of the ileal changes after transjugular intrahepatic portosystemic shunt placement: a case report. Journal of medical case reports 2011; 5: 90
Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000; 118(5): 905-911
Salerno F, Camma C, Enea M, Rossle M, Wong F. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 2007; 133(3): 825-834
Perarnau JM, Le Gouge A, Nicolas C, d'Alteroche L, Borentain P, Saliba F, Minello A, Anty R, Chagneau-Derrode C, Bernard PH, Abergel A, Ollivier-Hourmand I, Gournay J, Ayoub J, Gaborit C, Rusch E, Giraudeau B, group S-T. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: A randomized controlled trial. Journal of hepatology 2014
Bureau C, Pagan JC, Layrargues GP, Metivier S, Bellot P, Perreault P, Otal P, Abraldes JG, Peron JM, Rousseau H, Bosch J, Vinel JP. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver international : official journal of the International Association for the Study of the Liver 2007; 27(6): 742-747
Bai M, Qi X, Yang Z, Yin Z, Nie Y, Yuan S, Wu K, Han G, Fan D. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. Journal of gastroenterology and hepatology 2011; 26(6): 943-951
Fanelli F, Salvatori FM, Rabuffi P, Boatta E, Riggio O, Lucatelli P, Passariello R. Management of refractory hepatic encephalopathy after insertion of TIPS: long-term results of shunt reduction with hourglass-shaped balloon-expandable stent-graft. AJR American journal of roentgenology 2009; 193(6): 1696-1702
Riggio O, Ridola L, Angeloni S, Cerini F, Pasquale C, Attili AF, Fanelli F, Merli M, Salvatori FM. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. Journal of hepatology 2010; 53(2): 267-272
Clark TW, Agarwal R, Haskal ZJ, Stavropoulos SW. The effect of initial shunt outflow position on patency of transjugular intrahepatic portosystemic shunts. Journal of vascular and interventional radiology : JVIR 2004; 15(2 Pt 1): 147-152
Patel NH, Sasadeusz KJ, Seshadri R, Chalasani N, Shah H, Johnson MS, Namyslowski J, Moresco KP, Trerotola SO. Increase in hepatic arterial blood flow after transjugular intrahepatic portosystemic shunt creation and its potential predictive value of postprocedural encephalopathy and mortality. Journal of vascular and interventional radiology : JVIR 2001; 12(11): 1279-1284
Heinzow HS, Lenz P, Kohler M, Reinecke F, Ullerich H, Domschke W, Domagk D, Meister T. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis. World journal of gastroenterology : WJG 2012; 18(37): 5211-5218
Parvinian A, Shah KD, Couture PM, Minocha J, Knuttinen MG, Bui JT, Gaba RC. Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk. Journal of vascular and interventional radiology : JVIR 2013; 24(7): 941-946
Gaba RC, Couture PM, Bui JT, Knuttinen MG, Walzer NM, Kallwitz ER, Berkes JL, Cotler SJ. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation. Journal of vascular and interventional radiology : JVIR 2013; 24(3): 411-420, 420 e411-414; quiz 421
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution 3.0 License.